← Leaderboard
CAH
Ticker
CAH
Congressional Trades
9
by 4 members
Buys
5
56%
Sells
4
44%
Total Volume
$139K
midpoint
Unique Traders
4
members
Party Breakdown
Democrats5 · 56%
Republicans4 · 44%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
1▲
Jan '24
—
—
May '24
1▲
—
Jun '24
1▲
1▲
Aug '24
—
—
Sep '24
0▲1▼
—
Apr '25
1▲
0▲1▼
Sep '25
—
0▲1▼
Jan '26
—
0▲1▼
Feb '26
—
Democrats2▲3▼Net sellers
vs
Republicans3▲1▼Net buyers
Net buyingNet selling⚡ Party split
🏛️ Federal Contracts
all →- 2026-04-21$147KDepartment of Veterans AffairsFLUDEOXYGLUCOSE FDG F 18 - PET CT DOSE
- 2026-04-17$19KDepartment of Veterans AffairsPHARMACY ORDER MARIBAVIR 200MG
- 2026-04-17$17KDepartment of Veterans AffairsPHARMACY ORDER ARCALYST 220MG
- 2026-04-14$63KDepartment of Veterans AffairsPHILADELPHIA RADIOPHARM FDG
- 2026-04-09$1.7MDepartment of Veterans AffairsLENALIDOMIDE
- 2026-04-02$221KDepartment of Veterans AffairsCU-64 DETECTNET
- 2026-04-01$762KDepartment of Veterans AffairsTASK ORDER FOR OY 1 TO PROVIDE RADIOPHARMACEUTICAL PRODUCTS AS LISTED HEREIN, AS REQUESTED BY AUTHORIZED VA STAFF, IN ACCORDANCE WITH PUBLIC LAW 104-262 AND 38 USC 8153 IN ORDER TO SUPPORT THE VA CENTRAL IOWA HEALTH CARE SYSTEM.
- 2026-04-01$184KDepartment of Veterans AffairsXOFIGO RADIOPHARMACEUTICAL
- 2026-04-01$123KDepartment of Veterans AffairsXOFIGO RADIOPHARMACEUTICAL
- 2026-03-31$271KDepartment of Veterans AffairsRADIOPHARMACEUTICAL SUPPLIES
💼 Lobbying Filings
all →- 2026-04-20$1.3MCARDINAL HEALTH INCIssues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade p
- 2026-04-20$120KCARDINAL HEALTHProvide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
- 2026-04-20$80KCARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)General issues related to drug shortages, supply chain Federal budget issues
- 2026-04-20$30KCARDINAL HEALTH INC.Health care and FDA/agriculture appropriations. Enteral nutrition.
- 2026-04-17$60KCARDINAL HEALTH INC.General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs
- 2026-04-17$24KCARDINAL HEALTH INC.Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m
- 2026-01-20$740KCARDINAL HEALTH INCIssues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act). Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, tr
- 2026-01-20$120KCARDINAL HEALTHProvide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
- 2026-01-20$80KCARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)General issues related to drug shortages, supply chain Federal budget issues
- 2026-01-20$30KCARDINAL HEALTH INC.Health care and FDA/agriculture appropriations. Enteral nutrition.
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▲77
5 buys9 total4 sells
$107K buys · $32K sells
Cumulative Net Position (buy vol − sell vol)
+$75K
2024-019 trades plotted2026-02
Trade Activity Timeline
Congressional buys & sells by month · last 9 months w/ activity
24/01
24/05
24/06
24/08
24/09
25/04
25/09
26/01
26/02
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade4 buyers ·2 sellers
BuySellOtherDot size ∝ trade size · top 4 most-active traders shown
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay |
|---|---|---|---|---|
| 2026-02-05 | DRo Khanna | SELL | $1K – $15K | 32d |
| 2026-01-23 | DRo Khanna | SELL | $1K – $15K | 14d |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d |
| 2025-04-08 | RRobert Bresnahan | BUY | $1K – $15K | 30d |
| 2024-09-04 | RJohn James | SELL | $1K – $15K | 2d |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d |
| 2024-06-03 | RJohn James | BUY | $1K – $15K | 91d |
| 2024-05-02 | RJohn James | BUY | $1K – $15K | 123d |
| 2024-01-12 | DJonathan Jackson | BUY | $50K – $100K | 24d |